How to administrate erythropoietin, intravenous or subcutaneous?

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 6, 2013, Pages 579-583

  Costa, Simonetta ^a   Romagnoli, Costantino ^a   Zuppa, Antonio Alberto ^a   Cota, Francesco ^a   Scorrano, Antonio ^a   Gallini, Francesca ^a   Maggio, Luca ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anaemia of prematurity; Erythropoietin; Intravenous administration; Very low birthweight infants

Indexed keywords

FERRITIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ANEMIA; ARTICLE; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INFANT; LONG TERM CARE; MALE; NEUTROPENIA; PHLEBOTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; THROMBOCYTOSIS;

ANEMIA; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; HUMANS; HYPODERMOCLYSIS; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; RECOMBINANT PROTEINS; RETICULOCYTE COUNT; TRANSFERRIN;

EID: 84877581489     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12193     Document Type: Article

References (24)

1. Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birthweight: a multicenter, randomized controlled trial. Pediatrics 2001; 108: 934-42.
2. Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. The pharmacologic stability of human recombinant erythropoietin in commonly used neonatal intravenous solutions. Ann Pharmacother 1996; 30: 466-8.
3. Ohls RK, Veerman MW, Christensen RD,. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in parenteral nutrition solution. J Pediatr 1996; 128: 518-23.
4. Maier RF, Obladen M, Müller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin β ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002; 140: 8-15.
5. Stork EK, Carlo WA, Kliegman RM, Fanaroff AA,. Hypertension Redefined for Critically Ill Neonates. Pediatr Res 1984; 18: 321A.
6. Jobe AH, Bancalari E,. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-9.
7. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based on clinical staging. Ann Surg 1978; 187: 1-7.
8. Papile LA, Burstein J, Koffier H,. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 g. J Pediatr 1978; 92: 529-34.
9. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-9.
10. Hay WW Jr,. Strategies for feeding the preterm infants. Neonatology 2008; 94: 245-54.
11. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement:updatedguidelinesforreportingparallelgrouprandomisedtria. Ann Intern Med 2010; 152: 726-32. Epub 24 March.
12. Ohls RK, Harcum J, Schibler KK, Christensen RD,. The effect of erythropoietin on the transfusion requirement of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr 1997; 151: 661-5.
13. Warwood TL, Ohls RK, Lambert DK, Jones C, Scoffield SH, Gupta N, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006; 26: 296-300.
14. Bierer R, Roohi M, Peceny C, Ohls RK,. Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery. J Pediatr Surg 2009; 44: 1540-5.
15. Ohls RK,. Erythropoietin treatment in extremely low birthweight infants: blood in versus blood out. J Pediatr 2002; 140: 3-6.
16. Rigourd V, Kieffer F, Dommergues MA, Ayachi A, Assaf Z, Mohamed I, et al. Érythropoïétine chez le nouveau-né: efficacité comparée des voies d'administration sous-cutanée et intraveineuse. Arch Pédiatr 2004; 11: 319-26.
17. Buhrer C, Obladen M, Maier R, Müller C,. Urinary losses of recombinant erythropoietin in preterm infants. J Pediatr 2003; 142: 425-53.
18. Warwood TL, Ohls RK, Lambert DK, Leve EA, Veng-Pedersen P, Christensen RD,. Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates. J Perinatol 2006; 26: 636-9.
19. Caprara C, Grimm C,. From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 2012; 31: 89-119.
20. Aher SM, Ohlsson A,. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012; 10: CD004865. doi: 10.1002/14651858.CD004865.pub3.
21. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA,. Do recombinant human erythropoietin (rhEPO) and Iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 2000; 159: 627-8.
22. Romagnoli C, Tesfagabir MG, Giannantonio C, Papacci P,. Erythropoietin and retinopathy of prematurity. Early Hum Dev 2011; 87 (Suppl 1): S39-42.
23. Chen J, Smith LEH,. A double-edged sword: erythropoietin eyed in retinopathy of prematurity. Ophthalmology 2009; 116: 221-2.
24. Sears JE,. Stimulating angiogenesis to prevent ischemic retinopathy. Ophthalmology 2009; 116: 1597-8.